Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Share-based Compensation: 2010-2025

Historic Share-based Compensation for SRx Health Solutions (SRXH) over the last 13 years, with Q2 2025 value amounting to $2.9 million.

  • SRx Health Solutions' Share-based Compensation rose 26250.0% to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.6 million, marking a year-over-year decrease of 566.04%. This contributed to the annual value of $1.8 million for FY2023, which is 4000.0% down from last year.
  • Per SRx Health Solutions' latest filing, its Share-based Compensation stood at $2.9 million for Q2 2025, which was up 26250.0% from $300000.0 recorded in Q1 2025.
  • Over the past 5 years, SRx Health Solutions' Share-based Compensation peaked at $2.9 million during Q2 2025, and registered a low of $100000.0 during Q3 2024.
  • Its 5-year average for Share-based Compensation is $802235.3, with a median of $562000.0 in 2022.
  • Data for SRx Health Solutions' Share-based Compensation shows a peak YoY increase of 32094.59% (in 2021) and a maximum YoY decrease of 8963.58% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows SRx Health Solutions' Share-based Compensation stood at $623000.0 in 2021, then dropped by 12.36% to $546000.0 in 2022, then plummeted by 67.03% to $180000.0 in 2023, then tumbled by 44.44% to $100000.0 in 2024, then skyrocketed by 2800.0% to $2.9 million in 2025.
  • Its Share-based Compensation stands at $2.9 million for Q2 2025, versus $300000.0 for Q1 2025 and $100000.0 for Q3 2024.